Patient preference trial comparing capecitabine and S-1 in metastatic breast cancer patients

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2014
INTERVENTION: capecitabine S‐1 CONDITION: metastatic breast carcinoma PRIMARY OUTCOME: patient preference SECONDARY OUTCOME: PFS, OS, address quality of life (EORTC‐30), and anxiety and depression (HADS) INCLUSION CRITERIA: metastatic breast cancer patient
Epistemonikos ID: 3c8a119dcfe6c90212edcb1ba5e362daeebf1f87
First added on: Aug 22, 2024